Rhythm Pharmaceuticals, Inc.
RYTM
$59.93
-$0.25-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.34% | 0.88% | -35.39% | 77.18% | -239.57% |
| Total Depreciation and Amortization | 0.00% | -0.52% | -1.28% | -3.70% | -2.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.33% | 3.59% | 170.71% | -95.18% | 3,402.46% |
| Change in Net Operating Assets | -177.48% | 117.15% | 319.06% | 1.92% | -124.56% |
| Cash from Operations | -114.12% | 25.26% | 13.28% | 28.64% | -38.66% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.28% | 123.30% | -960.71% | -128.49% | 32.74% |
| Cash from Investing | 17.28% | 123.30% | -960.71% | -128.49% | 32.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -11.92% | 622.99% | 315.69% | -80.05% | 40.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.19% | -14.15% | -156.28% | 312.97% | -8.12% |
| Cash from Financing | -15.21% | 1,438.04% | -98.30% | 3,345.18% | 75.11% |
| Foreign Exchange rate Adjustments | -100.20% | 262.02% | -100.33% | -323.94% | 63.02% |
| Miscellaneous Cash Flow Adjustments | -- | 200.00% | -- | -- | -- |
| Net Change in Cash | -59.25% | 136.46% | -205.46% | 1,759.87% | -44.53% |